ArticleFrontiers in cell and developmental biology2022

Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids.

Yu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.